Alice B.
- Country
- France
- Department
- Service d’Infectiologie et de Médecine Interne
Research Overview
- A Phase II, randomised, placebo-controlled, double-blind, parallel-group, efficacy and safety study of at least 48 weeks of oral BI 685509 treatment in adults with progressive systemic sclerosis
- A Randomized, Double‑Blind, Placebo‑Controlled Trial of Oral Nerandomilast (BI 1015550) in Patients with Systemic Sclerosis
- Evaluation of Rituximab-Based Combination, Tocilizumab, and Tofacitinib in Granulomatosis with Polyangiitis Patients Unresponsive to Standard Therapy
Data & Insights
Has run more than one trial at 64 of 177 partner sites.
Specializations
Autoimmune Rheumatic Diseases
This investigator specializes in treating complex systemic sclerosis and dermatomyositis, exploring innovative therapeutic approaches including JAK inhibitors and targeted biologics for managing these conditions.
- Lung function in systemic sclerosis
- Skin fibrosis management
- Novel therapeutic interventions in dermatomyositis
The research focuses on evaluating treatments that can modify disease progression and improve patient outcomes.
Vasculitis Conditions
Expertise in treating various forms of vasculitis, including IgA vasculitis, granulomatosis with polyangiitis, and eosinophilic granulomatosis with polyangiitis.
- Rituximab-based therapies
- Salvage treatment strategies
- Mepolizumab interventions
Particular attention is given to developing glucocorticoid-sparing treatment approaches.
Lupus and Renal Disorders
Dedicated to advancing treatment options for lupus nephritis, with specific interest in corticosteroid-free therapeutic regimens using novel biological agents.
- Obinutuzumab-based treatments
- Mycophenolate mofetil combinations
- Steroid-sparing strategies
The focus is on achieving complete renal response while minimizing conventional steroid exposure.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.